Global Market for In Vitro Diagnostic Tests for Cancer to hit $8 billion by 2012, says New Report

PRLog (Press Release) – Jun 04, 2008 – Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report showing that the world market for in vitro diagnostic (IVD) tests for cancer is growing at nearly 11% annually and could reach nearly $8 billion by the end of 2012.

“The Worldwide Market for Cancer Diagnostics: 3rd Edition”, which is available at http://www.reportbuyer.com/go/KAL00058 reports that in addition to demographic and epidemiologic shifts, the cancer testing market is being driven by a number of advances in traditional technologies, biomarker development, and new clinical priorities.

According to the authors, the increased level of cancer screening, a public health priority as well as a healthcare cost priority, continues to drive some basic testing techniques such as fecal occult blood testing. Advances in pharmacodiagnostic technologies, aimed at refining treatment options and genetic and molecular tests to determine tumour growth pathways in the evaluation of patients at risk, are creating exciting opportunities for research development and offer the potential to open new market niches.

In addition to technology, the report notes that the emergence of the new paradigm that views cancer as a chronic disease has also been a boon for IVD developers. With advances in early screening and improved therapeutics, there is more need for cancer management and monitoring tests.

The report includes market size and growth forecasts to 2012; market segmentations by cancer type, IVD discipline, and geography; extensive discussions of technology development and penetration; and profiles of over 150 companies active in the segment.

“The Worldwide Market for Cancer Diagnostics: 3rd Edition” is available from Report Buyer. For more information go to:http://www.reportbuyer.com/pharma_healthcare/diseases/ca ...

Report Buyer product ID: KAL00058